Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Clearstead Trust LLC

Clearstead Trust LLC trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 74.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,366 shares of the pharmacy operator’s stock after selling 6,784 shares during the quarter. Clearstead Trust LLC’s holdings in Walgreens Boots Alliance were worth $51,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Quadrant Capital Group LLC raised its position in Walgreens Boots Alliance by 33.8% in the fourth quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock valued at $196,000 after purchasing an additional 1,893 shares during the period. Syon Capital LLC acquired a new stake in Walgreens Boots Alliance in the fourth quarter valued at approximately $333,000. New York Life Investment Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock valued at $3,008,000 after purchasing an additional 690 shares during the period. EP Wealth Advisors LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $297,000. Finally, Corient Private Wealth LLC boosted its stake in shares of Walgreens Boots Alliance by 38.9% in the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock valued at $7,325,000 after purchasing an additional 78,523 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA traded down $0.35 during mid-day trading on Friday, hitting $11.01. 80,864,506 shares of the company traded hands, compared to its average volume of 27,373,396. The business has a 50 day moving average of $14.61 and a two-hundred day moving average of $18.65. Walgreens Boots Alliance, Inc. has a 1 year low of $10.69 and a 1 year high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same period in the previous year, the company posted $1.00 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% on a year-over-year basis. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 9.08%. The ex-dividend date is Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Royal Bank of Canada cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. Truist Financial dropped their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Deutsche Bank Aktiengesellschaft reduced their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Barclays dropped their price target on shares of Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating for the company in a research note on Monday, June 24th. Finally, Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $17.71.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.